Franny’s Farmacy Expands National Reach Through Its Hemp Franchise and Retail Success
January 24th, 2023
News, Top News
ASHEVILLE, N.C.–(BUSINESS WIRE)–Pioneering hemp CBD brand Franny’s Farmacy today announced a strategic restructuring as the company expands nationwide. Shareholders of separate brand entities Franny’s Manufacturing and Franny’s Distribution are now shareholders in a new single entity—Franny’s Operations—representing the entire organization. The new business structure will further business collaborations and partnerships, while positioning Franny’s Farmacy as one of the most trusted consumer cannabis brands in the market.
Led by cannabis industry veteran and CEO Franny Tacy, Franny’s Farmacy is evolving with a new brand image, new products and more franchises poised to enter emerging recreational markets and existing legal-market cannabis states. Tacy is the first female hemp farmer in North Carolina in over 75 years and is actively engaged in hemp research trials with North Carolina State University. In the past decade, she has expanded the company from its headquarters in North Carolina to comprise 11 dispensaries in six states with a robust eCommerce portfolio and nationwide wholesale accounts.
“Franny Tacy has been a multifaceted leader in the nascent industrial hemp industry since its inception,“ said Robert Hoban, Global Cannabis Industry Expert and Co-Chair of Clark Hill Cannabis Industry Group. “She leads the everchanging hemp marketplace with a focus on its successfully implemented core competencies—retail, franchising, product development and supply chain management. The corporate restructure provides its current and future investors, customers, and employees with a design aimed to maximize tax efficiencies and affords it the ability to strategically expand into related endeavors across the country, and around the globe.”
Franny’s formulates a multitude of eco-friendly products from hemp foods to full-spectrum cannabinoid products designed for daily health and wellness. The company has also applied for Delta-9 THC licenses that will allow it to expand into legal cannabis markets.
About Franny’s Farmacy
Established in 2012, Franny’s Farmacy is a North Carolina-based, vertically integrated cannabis company dedicated to empowering personal health and wellness. A hemp farmer herself, founder Franny Tacy seeks to further U.S. hemp development and cannabinoid research while expanding consumer access to tested, quality-assured CBD and other plant-based products. With 11 dispensaries in six states and partnerships in legal THC markets, Franny’s Farmacy continues to grow its reach and influence. Learn more at frannysfarmacy.com.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.